Sichuan Hebang Biotechnology Corporation Limited (SHA: 603077)

Sichuan Hebang Biotechnology Corporation Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	3,061	3,064	4,591	1,711	845.86	590.52
Trading Asset Securities	-	-	-	56.89	-	206.03
Cash & Short-Term Investments	3,061	3,064	4,591	1,768	845.86	796.55
Cash Growth	-18.25%	-33.26%	159.70%	109.01%	6.19%	-41.94%
Accounts Receivable	3,032	2,049	2,568	1,656	1,682	1,121
Other Receivables	31.16	34.35	23.09	19.55	14.75	27.67
Receivables	3,063	2,084	2,591	1,675	1,697	1,149
Inventory	4,669	4,403	2,076	912.2	633.27	1,318
Other Current Assets	342.41	303.87	460.25	287.84	141.95	228.77
Total Current Assets	11,136	9,855	9,719	4,643	3,318	3,492
Property, Plant & Equipment	9,771	9,684	9,483	8,295	7,513	7,165
Long-Term Investments	819.04	667.27	677.37	661.99	645.59	369.25
Goodwill	1,838	1,838	1,838	1,904	1,904	1,904
Other Intangible Assets	2,185	2,200	2,143	1,967	1,018	1,088
Long-Term Deferred Tax Assets	51.33	50.38	110.3	25.83	85.94	38.7
Long-Term Deferred Charges	134.19	105.46	34.01	7.29	9.85	9.73
Other Long-Term Assets	288.23	142.16	97.84	417.19	245.29	417.62
Total Assets	26,223	24,542	24,103	17,922	14,740	14,484
Accounts Payable	2,829	1,877	1,877	1,156	1,042	971.08
Accrued Expenses	89.73	107.61	91.37	126.24	79.69	76.44
Short-Term Debt	2,194	1,168	1,222	1,171	1,602	1,593
Current Portion of Long-Term Debt	441.45	342.32	164	95	279	35.24
Current Portion of Leases	2.44	2.44	2.44	-	-	-
Current Income Taxes Payable	32.8	55.01	95.71	140.79	21.78	28.41
Current Unearned Revenue	79.71	96.6	235.07	371.54	113.74	1.28
Other Current Liabilities	24.37	20.83	46.5	62.07	13.87	79.02
Total Current Liabilities	5,694	3,670	3,734	3,123	3,152	2,785
Long-Term Debt	684.65	431.17	408.48	68.09	262.4	226
Long-Term Leases	21.96	24.94	21.54	37.06	-	-
Long-Term Unearned Revenue	70.75	75.25	79.03	16.79	15.86	17.15
Long-Term Deferred Tax Liabilities	134.05	122.75	96.02	39.99	2.3	2.96
Total Liabilities	6,605	4,324	4,339	3,285	3,433	3,031
Common Stock	8,831	8,831	8,831	8,831	8,831	8,831
Additional Paid-In Capital	1,141	1,125	1,095	470.46	212.9	212.9
Retained Earnings	10,398	10,204	9,313	5,642	2,619	2,578
Treasury Stock	-1,445	-650.37	-150	-700	-520.07	-400
Comprensive Income & Other	53.31	66.4	29.45	1.9	-1.24	11.31
Total Common Equity	18,978	19,575	19,118	14,245	11,142	11,233
Minority Interest	639.08	643.04	644.86	391.84	165.66	219.53
Shareholders' Equity	19,618	20,218	19,763	14,637	11,307	11,453
Total Liabilities & Equity	26,223	24,542	24,103	17,922	14,740	14,484
Total Debt	3,345	1,969	1,818	1,372	2,144	1,855
Net Cash (Debt)	-283.35	1,096	2,773	396.4	-1,298	-1,058
Net Cash Growth	-	-60.49%	599.57%	-	-	-
Net Cash Per Share	-0.03	0.13	0.32	0.05	-0.15	-0.12
Filing Date Shares Outstanding	8,095	8,512	8,725	8,394	8,518	8,606
Total Common Shares Outstanding	8,172	8,512	8,725	8,394	8,518	8,606
Working Capital	5,442	6,185	5,985	1,520	165.62	706.8
Book Value Per Share	2.32	2.30	2.19	1.70	1.31	1.31
Tangible Book Value	14,955	15,537	15,137	10,374	8,219	8,241
Tangible Book Value Per Share	1.83	1.83	1.73	1.24	0.96	0.96
Buildings	3,570	3,564	2,856	-	2,065	1,960
Machinery	11,738	11,677	10,357	-	7,313	6,732
Construction In Progress	1,663	1,174	1,885	-	2,320	2,087

Source: S&P Capital IQ. Standard template. Financial Sources.